Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603811.SS

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 14, 2025: 2.01

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 2.01 on January 14, 2025, a -23.95% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 2.65 on January 15, 2024, which is 31.50% above the current Price to Book Ratio (P/B).
  • Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.61 on July 16, 2024, which is -20.03% below the current Price to Book Ratio (P/B).
  • Zhejiang Cheng Yi Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 2.01.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
Shanghai Stock Exchange: 603811.SS

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

CEO Mr. Chunjian Zhao
IPO Date March 15, 2017
Location China
Headquarters No. 118, Chemical Road
Employees 738
Sector Health Care
Industries
Description

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs and capsules/tablets in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Wenzhou, China.

Similar companies

603367.SS

Cisen Pharmaceutical Co., Ltd.

USD 1.81

2.01%

603669.SS

Lionco Pharmaceutical Group Co.,Ltd.

USD 0.73

2.10%

603676.SS

Tibet Weixinkang Medicine Co., Ltd.

USD 1.34

5.04%

603538.SS

Ningbo Menovo Pharmaceutical Co., Ltd.

USD 1.70

3.24%

603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd.

USD 1.84

5.38%

StockViz Staff

January 15, 2025

Any question? Send us an email